We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

How Drug–Diagnostic Co-development is Shaping Discovery Research and Pharmacotherapy

Article   Mar 25, 2019 | Faezeh Koohestani & Sasidhar Murikinati, GenScript USA Inc.

 
How Drug–Diagnostic Co-development is Shaping Discovery Research and Pharmacotherapy
 
 
Advertisement
 

RELATED ARTICLES

Stay Up-to-Date With COVID-19 Drug Development

Article

Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

Keep Up-to-Date With COVID-19 Vaccine Development

Article

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

A New Way To Characterize Glycans From SARS-CoV-2's Spike Protein

Article

Dr Rod Chalk, head of mass spectrometry at The Centre for Medicines Discovery (previously the Structural Genomics Consortium) has developed a novel mass spectrometry-based method for characterizing glycans from the Spike protein. In this interview, Chalk discusses the method and how it can be adopted in SARS-CoV-2 research and beyond.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE